Report of the Second Equine Leucocyte Antigen Workshop, Squaw valley, California, July 1995.
about
Hematopoiesis in the equine fetal liver suggests immune preparedness.Use of flow cytometry to develop and characterize a set of monoclonal antibodies specific for rabbit leukocyte differentiation moleculesInterferon-gamma, interleukin-4 and interleukin-10 production by T helper cells reveals intact Th1 and regulatory TR1 cell activation and a delay of the Th2 cell response in equine neonates and foalsSplit immunological tolerance to trophoblast.Recombinant Streptococcus equi proteins protect mice in challenge experiments and induce immune response in horses.Failure of low-dose recombinant human IL-2 to support the survival of virus-specific CTL clones infused into severe combined immunodeficient foals: lack of correlation between in vitro activity and in vivo efficacy.Development of specific immunoglobulin Ga (IgGa) and IgGb antibodies correlates with control of parasitemia in Babesia equi InfectionEvaluation of immune responses following infection of ponies with an EHV-1 ORF1/2 deletion mutantCloning and large-scale expansion of epitope-specific equine cytotoxic T lymphocytes using an anti-equine CD3 monoclonal antibody and human recombinant IL-2Fell Pony syndrome: characterization of developmental hematopoiesis failure and associated gene expression profiles.Applied Protein and Molecular Techniques for Characterization of B Cell Neoplasms in Horses.Comparative Analysis of the Immunomodulatory Properties of Equine Adult-Derived Mesenchymal Stem Cells().Characterization and expression of monoclonal antibody-defined molecules on resting and activated bovine αβ, γδ T and NK cellsViral load and clinical disease enhancement associated with a lentivirus cytotoxic T lymphocyte vaccine regimen.Rhodococcus equi-infected macrophages are recognized and killed by CD8+ T lymphocytes in a major histocompatibility complex class I-unrestricted fashion.Lower airway disease, now and in the future.Characterization of an equine macrophage cell line: application to studies of EIAV infection.Contribution of each of four Superantigens to Streptococcus equi-induced mitogenicity, gamma interferon synthesis, and immunity.The different effector function capabilities of the seven equine IgG subclasses have implications for vaccine strategies.Complex interactions between the major and minor envelope proteins of equine arteritis virus determine its tropism for equine CD3+ T lymphocytes and CD14+ monocytes.Experimental Rhodococcus equi and equine infectious anemia virus DNA vaccination in adult and neonatal horses: effect of IL-12, dose, and route.Temporal analysis of equine bone marrow aspirate during establishment of putative mesenchymal progenitor cell populations.Reactivity of commercially available monoclonal antibodies to human CD antigens with peripheral blood leucocytes of dromedary camels (Camelus dromedarius).Novel classical MHC class I alleles identified in horses by sequencing clones of reverse transcription-PCR products.Effects of autologous stromal cells and cytokines on differentiation of equine bone marrow-derived progenitor cells.The effect of CpG-ODN on antigen presenting cells of the foal.Developmental expression of B cell molecules in equine lymphoid tissues.Characterization of respiratory dendritic cells from equine lung tissues.Highly deoxynivalenol contaminated oats and immune function in horses.Degenerative endometrial changes do not change the functional capacity of immigrating uterine neutrophils in mares.Deletion of the ORF2 gene of the neuropathogenic equine herpesvirus type 1 strain Ab4 reduces virulence while maintaining strong immunogenicity
P2860
Q30206834-7C1E98DB-7D5A-4640-87C0-66AAA34FE143Q33729951-CFD7F1D7-EBE7-4A87-B3EA-BFCA905FE229Q33834780-FE6F9553-9EA7-4712-AE12-0E0A8CF80F71Q33889253-E58625B5-7FEA-49AD-880D-6DA13F716EE1Q34142900-D40FA30A-33D8-4B3F-A1E8-DAF67C402576Q34257060-6749EB15-E455-4316-BAF6-9907573C0B6FQ34429334-B5562E36-D286-4C90-A7D7-4C28114D0B1BQ34607906-4F241BC9-36D1-40E4-8F3A-410748CE8B35Q36029988-12460081-C61A-4C50-8875-4666E86E80DEQ36086228-53D367C5-4959-4FB3-A603-B8FB2EF5B3C5Q36211658-C8B9FA9F-963E-4EF1-8E2E-54973CDF72E6Q36391489-87533571-718F-49A1-BC15-FCFF8F7900E2Q37397928-CE1BAA90-AF10-4A5C-A52D-CA14A949CFF9Q37412508-DB606D1A-D852-4503-AD4F-586B58910A0EQ37623921-031C7CE5-0356-4382-9AE2-22C774795F95Q37883473-A375A335-3F1A-4186-9193-C705CFF132AAQ39003919-CED7020A-0E7C-4221-8159-A1BF67A3849AQ39896685-D0DF5ECE-BD98-47EF-A82B-684520BB3A78Q40017444-CAA19B9A-9DAB-4320-B369-60C0CB08F5CBQ40341824-3D6F8345-6768-4EFB-BE53-A4CAFE2EC16FQ41787331-48CB1652-E5C6-4E3C-84ED-A39EFFA35180Q42078168-EE0C6D6F-522E-41F0-A4FB-D608D67DACF6Q42201576-B07303B0-73FA-438A-B318-E2D2FB955547Q42615511-3F790F0D-5870-41DE-85D7-769B0F696E7FQ42632321-994A4850-F06C-47EC-BD72-FCD7CB61B988Q42957702-ED01B021-2048-4451-BD6D-A769471FB0A4Q46435822-2D764605-D543-4F6A-8A25-7D0BFF69975AQ46928385-5D7818BD-81E2-4E71-8155-D373B636BA16Q47699661-6CDA26BC-FEA7-433D-965B-4F0FF474F67DQ47814482-DEA7708F-B37D-42F3-9563-0C1FB139EFCEQ57016879-4D2B3AEB-7D39-4F09-8545-AB6BD9D358E4
P2860
Report of the Second Equine Leucocyte Antigen Workshop, Squaw valley, California, July 1995.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年学术文章
@wuu
1998年学术文章
@zh
1998年学术文章
@zh-cn
1998年学术文章
@zh-hans
1998年学术文章
@zh-my
1998年学术文章
@zh-sg
1998年學術文章
@yue
1998年學術文章
@zh-hant
name
Report of the Second Equine Le ...... valley, California, July 1995.
@en
Report of the Second Equine Le ...... valley, California, July 1995.
@nl
type
label
Report of the Second Equine Le ...... valley, California, July 1995.
@en
Report of the Second Equine Le ...... valley, California, July 1995.
@nl
prefLabel
Report of the Second Equine Le ...... valley, California, July 1995.
@en
Report of the Second Equine Le ...... valley, California, July 1995.
@nl
P2093
P50
P1476
Report of the Second Equine Le ...... valley, California, July 1995
@en
P2093
B R Schram
K Cannizzo
K E Vagnoni
M A Holmes
M Blanchard-Channell
P304
P356
10.1016/S0165-2427(97)00160-8
P577
1998-03-01T00:00:00Z